Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina.

Anastassiou, G; Bornfeld, N; Schueler, A O; Schilling, H; Weber, S; Fluehs, D; Jurklies, B; Vij, O; Sauerwein, W

Anastassiou, G; Bornfeld, N; Schueler, A O; Schilling, H; Weber, S; Fluehs, D; Jurklies, B; Vij, O; Sauerwein, W.

Affiliation

Anastassiou G; Augenklinik, Universitätsklinikum Essen, 45122 Essen, Germany. gerasimos.anastassion@uni-essen.de

Br J Ophthalmol ; 90(4): 447-50, 2006 Apr.

Article in En | MEDLINE | ID: mdl-16547325

Subject(s)

Brachytherapy/methods; Neoplasms, Vascular Tissue/radiotherapy; Retinal Neoplasms/radiotherapy; Ruthenium Radioisotopes/therapeutic use; Brachytherapy/adverse effects; Cataract/etiology; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms, Vascular Tissue/pathology; Radiation Injuries/etiology; Retinal Neoplasms/pathology; Ruthenium Radioisotopes/adverse effects; Visual Acuity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Brachytherapy / Ruthenium Radioisotopes / Retinal Neoplasms / Neoplasms, Vascular Tissue Type of study: Diagnostic_studies / Etiology_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Br J Ophthalmol Year: 2006 Type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google